Pages that link to "Q37022903"
Jump to navigation
Jump to search
The following pages link to Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study (Q37022903):
Displaying 24 items.
- Diabetic kidney disease: from physiology to therapeutics (Q27021392) (← links)
- Early diabetic nephropathy in type 1 diabetes: new insights (Q27021632) (← links)
- Improvements in the Management of Diabetic Nephropathy (Q28080717) (← links)
- Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes. (Q33873175) (← links)
- Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetes (Q35123425) (← links)
- Renal hyperfiltration related to diabetes mellitus and obesity in human disease (Q35673442) (← links)
- The renal effects of SGLT2 inhibitors and a mini-review of the literature (Q37632127) (← links)
- Pathophysiology of the diabetic kidney. (Q38111707) (← links)
- The Gomez' equations and renal hemodynamic function in kidney disease research (Q38949048) (← links)
- Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment (Q39112475) (← links)
- Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats (Q41539692) (← links)
- Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes (Q42831084) (← links)
- Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitus (Q44792185) (← links)
- Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot study (Q45141864) (← links)
- The effect of aliskiren on urinary cytokine/chemokine responses to clamped hyperglycaemia in type 1 diabetes (Q46210012) (← links)
- Activation of general control nonderepressible 2 kinase protects human glomerular endothelial cells from harmful high-glucose-induced molecular pathways (Q46510122) (← links)
- Dapagliflozin in Focal Segmental Glomerulosclerosis: A Combined Human-Rodent Pilot Study. (Q47398861) (← links)
- Influence of sex on hyperfiltration in patients with uncomplicated type 1 diabetes (Q47905741) (← links)
- Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes (Q50101784) (← links)
- Ability of Cystatin C to detect changes in glomerular filtration rate after ACE inhibition in patients with uncomplicated type 1 diabetes (Q51356367) (← links)
- Urinary markers of renal inflammation in adolescents with Type 1 diabetes mellitus and normoalbuminuria (Q58811129) (← links)
- The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus (Q86124839) (← links)
- Role of sodium-glucose cotransporter 2 inhibition to mitigate diabetic kidney disease risk in type 1 diabetes (Q89465079) (← links)
- Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes (Q90316001) (← links)